Patient Advocacy Advisory Board

One of SNMMI’s goals is to engage the patient community and provide information about the uses of molecular imaging for improved diagnosis and treatment. The Society is committed to supporting patients, collaborating with patient advocacy organizations on issues of mutual interest, and providing educational programs to help patients understand molecular imaging and the role it can play in both diagnostic and therapeutic settings. To accomplish this, we have convened a Patient Advocacy Advisory Board to provide SNMMI staff, volunteer leaders, and members with the patient perspective. One of the board's first initiatives was to develop this website — a user-friendly resource about molecular imaging and therapy and those disease areas that are using molecular imaging. The content of this website has been reviewed, and will continue to be updated, by experts in the fields of nuclear medicine, cardiology, neurology, and oncology.

Patient Group Representatives

Dorothy McGrath Dorothy McGrath
Colorectal Cancer Alliance

Dorothy McGrath is a Stage IV colon cancer survivor.  When she was initially diagnosed in 2004, on her birthday, she wasn’t offered much hope for survival.  Being a researcher at heart, having worked at PBS affiliates for over 26 years, she educated herself on the disease and signed up for a Stage II clinical trial.  While researching her disease she joined the Colorectal Cancer Alliance and has been a mentor, advocate and speaker about this disease in order to raise awareness.  Her passion for producing health related programs for her local PBS station escalated.  Now that she is an insider on the disease, she has a true understanding of the challenges that patients face.  She hopes that her productions are more informative to meet the patients, and their caregiver’s needs.

Jeri Francoeur
Vice Chair
Susan G. Komen Foundation
Jeri Francoeur has been active with the Komen Foundation and numerous other breast cancer advocacy organizations, serving as chair of public policy for the Florida Breast Cancer Foundation and the Susan G. Komen Central Florida Affiliate. She is also a past chair of the Medical Quality Assurance Board for the state of Florida Board of Nursing Home Administrators. A breast cancer survivor who also lost a close friend to the disease, she is a passionate advocate for breast cancer research and funding, as well as patient education on treatment options. 

Rosemary Ciotti Rosemary Ciotti
FORCE: Facing Hereditary Cancer Empowered
Rosemary Ciotti is the consumer representative for FORCE, "Facing Our Risk of Cancer Empowered," a not-for-profit organization involved in research education and consumer support surrounding genetic risks for Breast and Ovarian cancers such as BRCA 1/2. Rosemary Ciotti is a nurse practitioner and President of Accessible Living, Incorporated of Arlington, Virginia. The company provides expert guidance in Americans with Disabilities Act (ADA) compliance, as well as, working with communities to increase the utility of the built environment through the concepts of Universal Design. Additionally, Accessible Living, Inc. coordinates health care for persons living in the community with spinal cord injuries. Rosemary is a frequent invited participant to conferences both locally and internationally. Rosemary is also Executive Director of “Global Organization of Feminists with Disabilities” (GOFWD) (501 c 3).

Crosby Mike "Bing" Crosby
Veterans Prostate Cancer Awareness Inc.

Mike “Bing” Crosby, Commander US Navy retired, was diagnosed with Prostate Cancer at the Phoenix VA in October of 2015. Given the relatively limited number of options for treatment through the Phoenix VA at the time, Mr. Crosby advocated for his own care outside the VA system and was subsequently treated by CyberKnife radiation therapy at the Swedish Hospital in Seattle WA. In December 2016 Mr. Crosby formed Veterans Prostate Cancer Awareness, a non-profit organization focused on raising awareness and educating our Nations Hero’s about the number ONE diagnosed non-skin cancer within the VA System. Veterans Prostate Cancer Awareness (VPCa) and ZERO – the End of Prostate Cancer (ZERO) are teaming up to address the startling prevalence of prostate cancer in the Veteran population. With over 489,000 patients currently in the VHA system undergoing treatment for prostate cancer, and almost 13,000 new cases each year, the disease is the number one reported solid tumor cancer in the VHA system. CDR Crosby holds a Master of Science in Systems Management from the University of Southern California in Los Angeles and is a 1983 graduate of the United States Naval Academy, with a Bachelor of Science in Applied Science. He is also a graduate of the Allied Air Forces Central Europe “Tactical Leadership Program”, as well as the US Navy Fighter Weapons School “TOPGUN”. Mr. Crosby has logged over 3000 hours in multiple tactical jet aircraft, including, the F-14, F/A-18, B-1B, Mirage 2000, Tornado GR1, Harrier, and the F-16N.

Amy Friedrich-Karnik, MPP
WomenHeart: The National Coalition for Women with Heart Disease

Amy Friedrich-Karnik is the Vice President of Advocacy and Communications at WomenHeart where she oversees the organization’s policy, advocacy, communications and marketing efforts to advance support and access to care for women living with and at risk for heart disease. Prior to joining WomenHeart, she was the Senior Federal Policy Advisor at the Center for Reproductive Rights, where she helped lead the Center’s federal policy work.  She focused on developing and implementing strategies to ensure protection for reproductive rights and access to reproductive healthcare in the U.S, regularly engaged with Congress and coalition allies, and oversaw the Act for Women campaign. Previously, Amy was an independent consultant, providing guidance to non-profit clients on policy and advocacy, development strategies, and project management on women’s health and caregiving issues.  Before going out on her own, Amy worked at Family Caregiver Alliance and for U.S. Representative Jan Schakowsky.  Amy received a Master of Public Policy degree from UCLA.

likowskiTerri Likowski

Terri has been on the staff of Us TOO International since 2005. In her current position as Program Director, she is the point person for more than 200 prostate cancer support group leaders across the country and abroad, and leads the expansion of the support group network. Through the professional relationships she has grown, she serves as the liaison for Us TOO connecting to the prostate cancer community and amplifies the voice of patients and caregivers.  In addition, Terri leads strategic program initiatives that provide prostate cancer educational resources, support services and personal connections through monthly support group leader training conference calls, support group leader webpage resource updates, training webinars, and support group leader roundtable discussions. She manages multiple patient and caregiver support services including “A Forum for Her” bi-weekly conference calls for wives and female partners of men with prostate cancer, and “The Gay Men’s Forum” monthly conference calls for gay men with prostate cancer and their husbands or partners.  Her impact extends to identifying and confirming prestigious prostate cancer physicians and medical experts to participate in the Us TOO Pathways educational event and webcast series. For the past 14 years, Terri has also had a leadership role in creating and implementing the annual SEA Blue Chicago Prostate Cancer Walk & Run, which draws more than 1,000 participants to raise awareness for prostate cancer and raise funds to support the work of Us TOO.

Josh MailmanJosh A. Mailman, MBA
NorCal CarciNET Community

Josh A. Mailman holds a BA in Economics from the University of California at Los Angeles and an MBA in Marketing and Finance from the Anderson School of Management at UCLA. He is a Silicon Valley executive with over 20 years of success in the technology field. Mr. Mailman co–created where he served as Vice President of Operations in addition to applying for and receiving several patents for his work on eFax’s technology. During his career Mr. Mailman has held executive level potions at Xerox, NBCi and Mr. Mailman’s last start-up, ChatterEmail was sold to Palm in 2007. Since his diagnosis in 2006 Mr. Mailman has focused his time and energy in the Non-profit community. He currently serves on the executive board of the Neuroendocrine Tumor Research Foundation (, as president of the Northern California Carcinoid/Neuroendocrine Support Group (, as Chief Operating Officer of WARMTH, and as a member of the NCI Steering Committee on GI Cancer.

Alison Manson, MPH
ZERO, The End of Prostate Cancer
Alison Manson, Vice President Government Relations & Advocacy at ZERO, The End of Prostate Cancer, is an experienced government relations professional with expertise in health policy.  Prior to her position at ZERO, she served as Associate Director of Federal Government Relations with the American Optometric Association, representing the concerns of doctors of optometry and their patients before policymakers.  Ms. Manson also worked for Prevent Blindness, as Director of Government Affairs, leading their work to enact policy to improve vision health and reduce vision impairment across the country.  She has also worked for the National Coalition on Health Care, developing strategies to make the American health system more sustainable, affordable, and fair.  Ms. Manson began her career with the National Rural Health Association, working to improve health policy and the lives of rural Americans.  Ms. Manson earned a Masters of Public Health from the George Washington University and a B.A. from the University of Virginia.  Alison has a passion for doing good and has supplemented her professional responsibilities with volunteer leadership positions at the national level with the American Public Health Association and the Del Ray Farmers’ Market.  Ms. Manson lives in Alexandria, Virginia, with her husband and three children. 

 Anita McGlothlin
Go2 Foundation for Lung Cancer

Anita McGlothlin is the Director of Economics and Regulatory Affairs at the Go2 Foundation for Lung Cancer (Go2), a Washington, D.C.-based national nonprofit organization whose mission is to save lives and advance research by empowering those living with and at risk for lung cancer. Anita works closely with the Patient and Outreach Services, Health Policy, and Science and Research programs to advance the Go2's mission through the development and implementation of priority science and regulatory policies.  Having led low dose CT lung cancer screening national coverage efforts for radiology in her prior role, and with over twenty years of economics and health policy expertise, Anita has a special interest in reducing patient access barriers and increasing the lung cancer screening rates. In addition to her career in screening and policy, Anita was appointed to the National Lung Cancer Roundtable as the Vice Chair of the Policy Action Task Group, which is a partnership of public, private and voluntary organizations that play a key role in reducing the incidence of and mortality from lung cancer. Over 156,000 Americans will die annually from lung cancer and like so many other families impacted, Anita’s advocacy work holds a personal story.

Moravek Cassadie Moravek
Pancreatic Cancer Action Network
Cassadie Moravek is the Associate Director of Scientific and Medical Affairs at the Pancreatic Cancer Action Network (PanCAN). PanCAN is dedicated to fighting the world’s toughest cancer, attacking pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Our effort is amplified by a nationwide network of grassroots support. We are determined to accelerate progress and improve patient outcomes. In her role, Cassadie oversees the organization’s patient research initiatives, including the Know Your Tumor® precision medicine service, the Patient Registry, and Clinical Trial Finder. She works closely with the organization’s Patient Services call center to ensure these services are offered to the appropriate patients and are easy to use and effective. In addition, she works with the Scientific and Medical Affairs team to collect, analyze, and publish data contributing to best practices in the field. Cassadie also represents PanCAN in several advisory roles, including serving as a Patient Advocate on the National Cancer Institute (NCI) Pancreas Task Force, for the review panel for the National Comprehensive Cancer Network (NCCN) Pancreatic Adenocarcinoma Guidelines and for the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancer Guideline Advisory Group and Pancreatic Cancer Guidelines.

Joel Nowak
Cancer ABCs
Joel T. Nowak, MA, MSW, is a cancer thriver and advocate who has been diagnosed and treated for five primary cancers, including advanced prostate cancer.  He is a co-founder and CEO of Cancer ABCs, which has as its mission to facilitate tangible improvements in the lives of people who have been affected by cancer(s), by providing them and their loved ones the necessary survival tools, education, support and advocacy so that they can become responsible for and take an active role in their own medical care and wellbeing.  Joel also serves as a programmatic reviewer for the Department of Defense Prostate Cancer Research Program, is a member of the External Patient Review Board for the Herbert Irving Cancer Center at Columbia Presbyterian Hospital, is on the Advisory Board for the Prostate Cancer Clinical Trial Consortium (PCCTC), where he is also an active member of the team developing the Ironman Study, and the DORA Trial.  Joel was involved in the development of the Metastatic Prostate Cancer Project with the Broad Institute.  He has been involved in the development of clinical trial protocols with a number of trials actively being considered for funding. He has published numerous plain language documents, blogs, and papers for cancer patients and their caregivers. 

Claudia Revilla
Michael J Fox Foundation
Claudia was diagnosed with Young Onset Parkinson's disease 10 years ago.   Her Parkinson’s journey led her to the realization that the disease is a progressive neurological disorder without a cure, defined biomarker, or effective treatment options.  Claudia decided to get involved with the Michael J Fox Foundation to further educate herself and work to increase research and find new therapies to treat the disease.  As a dedicated volunteer at MJF, Claudia is an active participant in clinical trials and a committed public policy advocate.  She lives in Peoria, IL with her husband and their two sons.  

Stephen Schwartz Stephen J. Schwartz
Lymphoma Research Foundation

Stephen Schwartz serves as the Lymphoma Research Foundation (LRF) representative, a survivor of Diffusive large B-cell lymphoma. Stephen’s involvement with LRF was at the onset of his 1998 non-Hodgkin lymphoma diagnosis through the Cure for Lymphoma Foundation (CLF), which later merged with the Lymphoma Research Foundation of America to become the Lymphoma Research Foundation. Stephen serves on LRF’s Regional Leadership Council and was a member of the Public Policy Committee. He is the inaugural recipient (July 2017) of the Marnie Gordon Founder’s Award. Stephen spent six years working in energy efficiency at Lime Energy, having served in senior positions including Program and Finance Director. Stephen has more than 20 years of international experience as a media sales and marketing, business-to-business professional in digital, print, conference, and trade shows. More than half has been in the science (STM) and chemical industries, first at Chemical Week (IHS Markit) then Nature Publishing Group (NPG), a division of Macmillan Publishers Limited, part of Springer Nature. At NPG, Stephen directed all U.S. advertising sales (print, digital and podcast) for Nature, the world’s leading scientific journal, as well as 17 other monthly titles including Nature Biotechnology, Nature Genetics, as well as aiding in the launch of Nature Methods. Stephen lives with his family in New York and is a graduate of the Boston University Questrom School of Business.

Christopher Weber, PhD
Alzheimer's Association

Dr. Weber, director of Global Science Initiatives, oversees efforts to advance the scientific agenda of the Alzheimer’s Association. With over 20 years of clinical research experience, Dr. Weber is responsible for communicating the global research landscape of Alzheimer’s and dementia, including the breadth and reach of the Association’s research programs, and the critical need for increased research funding from the public and private sectors.
Dr. Weber directs Association initiatives that convene leaders from across the field to develop, expand and increase the success rate of Alzheimer’s diagnostic tools and drugs to treat and prevent the disease. He manages the Alzheimer’s Association Research Roundtable, a platform that enables international scientific, industry and government leaders to overcome shared obstacles in Alzheimer’s science and drug development. He also oversees the Global Biomarker Standardization Consortium (GBSC), an initiative that unites key researchers and clinicians with industry, regulatory and government leaders to achieve consensus on the best ways to standardize and validate biomarker tests for use in clinical practices worldwide. Dr. Weber received his doctorate in clinical psychology from the Illinois Institute of Technology.

Theresa Wickerham Theresa Wickerham
ThyCa: Thyroid Cancer Survivors' Association

Theresa Wickerham began volunteering for ThyCa: Thyroid Cancer Survivors’ Association in 2000. Following her original thyroid cancer diagnosis in 1975 she went 25 years without meeting anyone with thyroid cancer. She had a recurrence in 1998. During this more recent treatment experience she found some information about thyroid cancer on the Internet and also virtually met thyroid cancer survivors. This empowerment helped her realize that no one should go through a thyroid cancer diagnosis and journey alone and without the knowledge necessary to make good choices. She decided to get involved and make a difference. She founded the St. Louis Thyroid Cancer Survivors’ Support Group, organized several one-day regional workshops throughout the Midwest, and has taken on more and more involved planning and coordination roles in ThyCa’s International Thyroid Cancer Survivors’ Conferences including hosting the meeting in St. Louis, Missouri, in 2008 and 2015. In 2012 Theresa took the position of Program Coordinator for ThyCa. In this role she furthers education and support programs for all people dealing with a thyroid cancer diagnosis. She lives outside of St. Louis, Missouri, with her husband and enjoys spending time with their children and grandchildren.

SNMMI Outreach Committee Representatives

Bital Bital Savir-Baruch, MD 
SNMMI Outreach Co-Chair

Dr. Savir-Baruch is a Nuclear Medicine Assistant Professor in the Nuclear Medicine Division, Department of Radiology at Loyola University Medical Center, Maywood, Illinois. Dr. Savir-Baruch is a board certified Nuclear Medicine physician. She received her medical degree with honors from Semmelweis University, Budapest, Hungary. After completing a two-year research fellowship in the Department of Radiology at Emory University, Atlanta, GA, she joined the Nuclear Medicine residency program. While at Emory, Dr. Savir-Baruch continued to advance as a clinical physician, medical educator, and researcher.  Dr. Savir-Baruch has been at Loyola University Medical Center, as an Assistant Professor of Radiology since 2014. Along with her position as a Nuclear Medicine Attending physician, she serves as a research and education mentor for medical students and residents. Additionally, Dr. Savir-Baruch was appointed as a mentor
at the "Education Pathway" program, designed for elite radiology residents at Loyola. Her main research interest lies in the innovation of new techniques to guide invasive procedures and investigate novel radiotracers and imaging devices in the detection and management of neoplastic diseases. She serves on the SNMMI Prostate Cancer Outreach Working Group and is also an active member of ACNM, ASNC, RSNA and ACR societies.

Chadwick Wright, MD, PhD
SNMMI Outreach Co-Chair

Dr. Chadwick Wright is an Assistant Professor of Radiology in the Division of Molecular Imaging & Nuclear Medicine at The Ohio State University Wexner Medical Center. He is dual board-certified in diagnostic radiology and nuclear medicine. Dr. Wright’s clinical efforts focus on clinical nuclear medicine and targeted radiotherapy. His research interests focus on the development and assessment of new imaging technologies and imaging agents related to: (1) next generation PET technologies, (2) PET imaging for theranostics, and (3) clinical trials using nuclear medicine methodologies. Dr. Wright also actively participates in the imaging core lab for IROC Ohio (Imaging and Radiation Oncology Cooperative) for the NCI NCTN. He has previously served on the Board of Directors for the SNMMI PET Center of Excellence and continues to serve as Outreach Champion for the SNMMI Central Chapter as well as other SNMMI committees.

SNMMI Leadership

Alan B. Packard, PhD
SNMMI President

Alan Packard, PhD, is associate professor of radiology at Harvard Medical School, director of radiopharmaceutical research and a senior research associate in nuclear medicine at Boston Children's Hospital in Boston, MA. 

Packard’s laboratory at Boston Children’s Hospital is engaged in the development of radiolabeled proteins for multiple applications, including cancer imaging and therapy, and 18F-labeled small molecules for myocardial perfusion imaging. The focus of the cancer program is on developing copper-64 (64Cu)- and zirconium-89 (89Zr)-labeled antibodies that can be used to noninvasively evaluate disease status, as well as on developing antibodies labeled with therapeutic radionuclides, such as lutetium-177 (177Lu) and copper-67 (67Cu), that can be used to treat cancer.

A prolific researcher, author and editor, Packard has coauthored more than 70 articles and has written book chapters on topics ranging from pediatric nuclear medicine and new procedures in nuclear medicine to application of nanoparticles in medical imaging. He is a regular lecturer and invited speaker at conferences across the United States and around the world. He is a reviewer for a variety of journals, including The Journal of Nuclear Medicine, Nuclear Medicine and Biology, Inorganic Chemistry, The Journal of Inorganic Biochemistry, Cancer Research, Molecular Imaging, Bioconjugate Chemistry, Cancer Biotherapy & Radiopharmaceuticals, The Journal of Medicinal Chemistry, Applied Radiation and Isotopes, and the Journal of the American Chemical Society. He is currently on the advisory board for Molecular and Cellular Therapies.

A longtime SNMMI member, Packard has served on the society’s board of directors. He is currently chair of the Education Committee and has chaired and served on many committees and task forces in past years. He is a member of the society’s Radiopharmaceutical Science Council and Center for Molecular Imaging, Innovation and Translation. He is also an active member of the American Chemical Society and the Society of Radiopharmaceutical Sciences. Packard has a bachelor’s degree in chemistry from the University of New Hampshire and a PhD in inorganic chemistry from Colorado State University.

Tina M. Buehner, MS, CNMT, RT(N)(CT), NMTCB(CT)(RS), FSNMMI-TS
President, SNMMI Technologist Section

Tina M. Buehner is a health physicist specialist at Rush University Medical Center in Chicago, Illinois. Buehner has close to 20 years of experience as a nuclear medicine technologist. She worked as the manager of the nuclear medicine/nuclear cardiology at Loyola University Health System’s Gottlieb Memorial Hospital in Melrose Park, Illinois, for five years and as a staff technologist and clinical educator at Northwestern Memorial Hospital in Chicago for 14 years before taking her current position.

Currently a director-at-large on the SNMMI Board of Directors, Buehner has also served as a delegate on the SNMMI House of Delegates since 2011, on the SNMMI-TS National Council of Representatives since 2011, and on the SNMMI-TS Awards, Grants, and Scholarships Committee since 2010. Very active within the Central Chapter of SNMMI, Buehner serviced as chair of the Membership and Programs committees, on the technologist Educator’s Task Force, and as technologist chapter president from 2014 to 2016. Outside of SNMMI, she has served on the Nuclear Medicine Technology Certification Board (NMTCB) since 2015 and was the SNMMI-TS representative to the Associated Sciences Committee for the Radiological Society of North America in 2016-2017.

Buehner was named a fellow of SNMMI-TS in 2015. She was accepted to and completed the Society of Nuclear Medicine (SNM)/IBA Leadership Academy in 2010. She won the Northwestern Memorial Hospital’s Employee Excellence Award in 2010 and the SNM’s Paul Cole Scholarship in 2001. Her publications include five journal articles, two book chapters, and many invited speaker presentations.

She completed her AAS in nuclear medicine technology at Triton College in River Grove, Illinois, followed by a bachelor’s degree in Health Arts and a master’s degree in health services administration at the University of St. Francis in Joliet, Illinois. Buehner is passionate about research and is currently in the last semester of a doctoral program in health sciences at Rush University in Chicago. Her current project through Loyola University Medical Center is evaluating 18F-fluciclovine in gynecological cancers.